drugset / Trial / NCT00121719
An Open Label Dose Escalation Study Of E7080
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the maximum tolerated dose (MTD) of lenvatinib in patients with solid tumors or lymphomas.
Timeline
- Start
- 2005-07-01
- Primary completion
- 2009-06-19
- Completion
- 2019-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lenvatinib | Small molecule | — | Oral |